Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

A Clinical Trial to Evaluate the Effects of an Omega-3-containing Supplement on DHA and EPA Levels in the Blood

Revive Active · with Citruslabs · NCT07753174

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–65 · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Not applicable
Target enrollment
49
US sites recruiting
1
Study start
September 2026
Record last updated
August 7, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

This is a 12-week, hybrid, single-arm clinical trial designed to evaluate the effects of an omega-3-containing supplement (Omega Active) on DHA and EPA levels in the blood. Forty participants will take two capsules of the test product daily and complete study-specific questionnaires at Baseline, Week 4, Week 8, and Week 12, while also attending their local Quest Diagnostics Center at Baseline and Week 12 for blood biomarker testing.

The study will also assess participants' perceptions of the effects of the test product on cognitive performance, gastrointestinal symptoms, and overall health through self-reported questionnaires. There is no randomization or blinding; all participants will receive the active supplement for the full 12-week intervention period.

Being studied: Omega Active Supplement

Conditions: Omega-3 Deficiency; DHA and EPA Blood Levels; Cardiovascular Health; Cognitive Health

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Be male or female.
  • Be aged 18-65.
  • Anyone in good general health.
  • Willing to avoid taking other supplements, prescription medications, or herbal remedies that target DHA or EPA levels in the body, for the duration of the study.
  • Must not have taken fish oil or plant-based omega oil supplements in the past eight weeks.
  • Willing to maintain their current diet, sleep schedule, and activity level for the duration of the study.
  • Resides in the United States.

Exclusion Criteria

  • Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders.
  • Anyone on anticoagulants or antiplatelet therapy.
  • Anyone with a bleeding disorder.
  • Anyone with any allergies or sensitivities to any of the study product ingredients.
  • Any women who are pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period).
  • Anyone unwilling to follow the study protocol.
  • Anyone who does not consume any specific dietary ingredients for any reason.
  • Currently partaking in another research study or will be partaking in any other research study at any point during this study's duration.

Recruiting US locations

Study contacts (from the official record)

  • Patrick Renner · 4242450284
A Clinical Trial to Evaluate the Effects of an Omega-3-containing… (NCT07753174) | Bored Studies